|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Washington Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Carepeutics, Inc.
| Carepeutics, Inc. 550 17th Ave., Suite 550 Seattle, WA 98122 | |
| | Phone: | (206) 281-3915 | Year Established: | 2009 | Main Contact: | Glenn Kawasaki, Founder, President & CEO | | Company Description | Carepeutics is developing a novel diagnostic method to predict patient responses to cancer drugs. The company’s initial focus is glioblastoma multiforme (GBM), a deadly brain cancer that is often treated with temozolomide (TMZ). However, only about 50% of patients respond to TMZ. In the proposed studies, GBM patients at Swedish Medical Center will be given lightly radiolabeled TMZ before tumor removal, and Carepeutics and Accium BioSciences personnel will analyze patient specimens to identify molecular profiles that are associated with poor responses to TMZ. Success with GBM could allow Carepeutics to expand its technology to other diseases with larger markets. | |
|
|
|
|
|